Enteric pathogenic bacteria and resistance gene carriage in the homeless population in Marseille, France.

Escherichia coli pathotypes Tropheryma whipplei antibiotic resistance gene enteric bacteria homeless real-time polymerase chain reaction (qPCR)

Journal

Acta microbiologica et immunologica Hungarica
ISSN: 1588-2640
Titre abrégé: Acta Microbiol Immunol Hung
Pays: Hungary
ID NLM: 9434021

Informations de publication

Date de publication:
27 Jan 2021
Historique:
received: 16 11 2020
accepted: 02 12 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 30 1 2021
Statut: aheadofprint

Résumé

We aimed to assess the prevalence of pathogenic bacteria and resistance genes in rectal samples collected among homeless persons in Marseille, France. In February 2014 we enrolled 114 sheltered homeless adults who completed questionnaires and had rectal samples collected. Eight types of enteric bacteria and 15 antibiotic resistance genes (ARGs) were sought by real-time polymerase chain reaction (qPCR) performed directly on rectal samples. ARG-positive samples were further tested by conventional PCR and sequencing. We evidenced a 17.5% prevalence of gastrointestinal symptoms, a 9.6% prevalence of enteric pathogenic bacteria carriage, including Escherichia coli pathotypes (8.7%) and Tropheryma whipplei (0.9%). Only 2 persons carried blaCTX-M-15 resistance genes (1.8%), while other genes, including carbapenemase-encoding genes and colistin-resistance genes, (mcr-1 to mcr-6, mcr-8) were not detected. Our results suggest that sheltered homeless persons in Marseille do not have a high risk of harbouring gastrointestinal antibiotic resistant bacteria.

Identifiants

pubmed: 33512334
doi: 10.1556/030.2021.01346
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tran Duc Anh Ly (TDA)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.

Linda Hadjadj (L)

2IHU-Méditerranée Infection, Marseille, France.
3Aix Marseille University, MEPHI, Marseille, France.

Van Thuan Hoang (VT)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.
6Pneumology Department, Thai Binh University of Medicine and Pharmacy, Thai Binh, Viet Nam.

Ndiaw Goumbala (N)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.
5VITROME, Campus International IRD-UCAD de l'IRD, Dakar, Senegal.

Thi Loi Dao (TL)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.
4Family Medicine Department, Thai Binh University of Medicine and Pharmacy, Thai Binh, Viet Nam.

Sekene Badiaga (S)

2IHU-Méditerranée Infection, Marseille, France.
7Aix Marseille University, Service des urgences CHU Hôpital Nord, Marseille, France.

Herve Tissot-Dupont (H)

2IHU-Méditerranée Infection, Marseille, France.
3Aix Marseille University, MEPHI, Marseille, France.

Philippe Brouqui (P)

2IHU-Méditerranée Infection, Marseille, France.
3Aix Marseille University, MEPHI, Marseille, France.

Didier Raoult (D)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.
3Aix Marseille University, MEPHI, Marseille, France.

Jean-Marc Rolain (JM)

2IHU-Méditerranée Infection, Marseille, France.
3Aix Marseille University, MEPHI, Marseille, France.

Philippe Gautret (P)

1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
2IHU-Méditerranée Infection, Marseille, France.

Classifications MeSH